Ding Wenjin, Fan Jiangao, Qin Jianjun
Department of Gastroenterology, Xinhua Hospital, Shanghai Jiao Tong University School of Medicine Shanghai, China.
Shanghai Institute of Disaster Prevention and Relief, Tongji University Shanghai, China.
Int J Clin Exp Med. 2015 Jan 15;8(1):322-33. eCollection 2015.
Several existing studies indicated that nonalcoholic fatty liver disease (NAFLD) may be associated with colorectal adenoma, but the results and risk factors are controversial. A systematic review of studies was conducted to explore these issues by meta-analysis.
We searched the Pubmed, Embase, Cochrane library, Medline and Web of Science databases for studies published before May 30(th), 2014. A statistical analysis was performed using RevMan 5.2 software.
Seven studies involving 11,905 participants from different regions were included. Among them, five trials carried out subgroup of NAFLD patients in colorectal adenoma population. The result showed NAFLD was significantly correlated with adenoma of colon (Odds ratio [OR] = 1.56, 95% confidence interval [CI]: 1.22-1.99, P = 0.0003). It could be found in stratified analysis that patients had more chance to get multiple adenomas when they suffered NAFLD (Rate ratio [RR]: 1.52, 95% CI: 1.08-2.13, P = 0.02). Such risk factors of NAFLD as age, waist circumference, body mass index (BMI), disorder of lipid metabolism, hyperglycemia and high blood pressure (HBP) increased risk of colorectal adenoma (Age: mean difference [MD]: 2.81, 95% CI: 0.33-5.28; Waist: MD: 2.84, 95% CI: 2.14-3.54; BMI: MD: 0.85, 95% CI: 0.69-1.01; High-density lipoprotein: MD: -2.46, 95% CI: -3.68 to -1.24; Triglyceride: MD: 16.12, 95% CI: 8.89-23.36; Low-density lipoprotein: MD: 6.04, 95% CI: 3.60-8.48; Cholesterol: MD: 4.25, 95% CI: 0.87-7.63; Fasting glucose: MD: 2.27, 95% CI: 1.24-3.30; HBP: OR = 1.51, 95% CI: 1.22-1.88), while diabetes had no significant association with it (OR = 1.43, 95% CI: 0.94-2.17, P = 0.09). Besides, NAFLD didn't affect the location, size and advanced type of colorectal adenoma (P > 0.05).
The present systematic review and meta-analysis demonstrated NAFLD was closely associated with great risk of colorectal adenoma and its number, but not with its location, size and advanced type. Waist, obesity, lipid profiles, glucose, hypertension played roles in the process of colorectal adenoma.
多项现有研究表明,非酒精性脂肪性肝病(NAFLD)可能与结直肠腺瘤有关,但结果和危险因素存在争议。通过荟萃分析对相关研究进行系统评价以探讨这些问题。
检索Pubmed、Embase、Cochrane图书馆、Medline和Web of Science数据库中2014年5月30日前发表的研究。使用RevMan 5.2软件进行统计分析。
纳入7项研究,共11905名来自不同地区的参与者。其中,5项试验在结直肠腺瘤人群中对NAFLD患者进行了亚组分析。结果显示,NAFLD与结肠腺瘤显著相关(优势比[OR]=1.56,95%置信区间[CI]:1.22 - 1.99,P = 0.0003)。分层分析发现,NAFLD患者发生多个腺瘤的机会更多(率比[RR]:1.52,95% CI:1.08 - 2.13,P = 0.02)。NAFLD的年龄、腰围、体重指数(BMI)、脂质代谢紊乱、高血糖和高血压(HBP)等危险因素增加了结直肠腺瘤的风险(年龄:平均差[MD]:2.81,95% CI:0.33 - 5.28;腰围:MD:2.84, 95% CI:2.14 - 3.54;BMI:MD:0.85,95% CI:0.69 - 1.01;高密度脂蛋白:MD:-2.46, 95% CI:-3.68至-1.24;甘油三酯:MD:16.12, 95% CI:8.89 - 23.36;低密度脂蛋白:MD:6.04, 95% CI:3.60 - 8.48;胆固醇:MD:4.25, 95% CI:0.87 - 7.63;空腹血糖:MD:2.27,95% CI:1.24 - 3.30;HBP:OR = 1.51, 95% CI:1.22 - 1.88),而糖尿病与之无显著关联(OR = 1.43, 95% CI:0.94 - 2.17, P = 0.09)。此外,NAFLD不影响结直肠腺瘤的位置、大小和进展类型(P>0.05)
本系统评价和荟萃分析表明,NAFLD与结直肠腺瘤及其数量密切相关,但与位置、大小和进展类型无关。腰围、肥胖以及血脂、血糖、高血压在结直肠腺瘤的发生过程中起作用